Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.
A H S AligD P ModestS StintzingK HeinrichM GeisslerL Fischer von WeikersthalT DeckerU Vehling-KaiserS HeldN MoosmannA StahlerA TannapfelC Giessen-JungA JungL WeissV HeinemannPublished in: ESMO open (2024)
This analysis suggests that PTS has predictive value for the efficacy of anti-EGFR mAb in the first-line treatment of BRAFmt mCRC.